A Plus Biotechnology , Ltd. Current Assets

A Plus Biotechnology , Ltd. (6918.TWO) currently reports a current assets of $1.2B as of March 2026. That compares with $950M in the prior-year period — up 27.1% year over year. Use the charts on this page to explore A Plus Biotechnology , Ltd.'s current assets history and peer comparisons.

A Plus Biotechnology , Ltd.'s current assets increased from $950M to $1.2B — a 27.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

A Plus Biotechnology , Ltd. reported $1.2B in current assets as of March 2026. That compares with $950M in the prior-year period — up 27.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for A Plus Biotechnology , Ltd., and consider following 6918.TWO for alerts when major investors trade the stock.